Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.62 |
| ▸ | TTR | P02766 | 3/20 | 0.58 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.52 |
| ▸ | AKR1C1 | Q04828 | 4/20 | 0.52 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.52 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.52 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.46 |
| ▸ | GLRB | P48167 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.46 |
| ▸ | TSHR | P16473 | 5/20 | 0.46 |
| ▸ | HPGD | P15428 | 4/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29396580 | 0.88 | DPP4 (0.56) | DPP4TTRAKR1C2AKR1C1AKR1C4 | |
| SCHEMBL1229004 | 0.88 | DPP4 (0.56) | DPP4TTRAKR1C2AKR1C1AKR1C4 | |
| SCHEMBL940604 | 0.86 | DPP4 (0.54) | DPP4TTRAKR1C2AKR1C1AKR1C4 | |
| SCHEMBL941588 | 0.86 | DPP4 (0.54) | DPP4TTRAKR1C2AKR1C1AKR1C4 | |
| SCHEMBL5318766 | 0.86 | AKR1C2 (0.61) | DPP4TTRAKR1C2AKR1C1AKR1C4 | |
| SCHEMBL20233406 | 0.84 | DPP4 (0.52) | DPP4TTRAKR1C2AKR1C1AKR1C4 | |
| SCHEMBL2787863 | 0.84 | DPP4 (0.57) | DPP4TTRAKR1C2AKR1C1AKR1C4 | |
| SCHEMBL8797780 | 0.83 | HSD17B10 (0.52) | DPP4TTRAKR1C2AKR1C1AKR1C4 | |
| SCHEMBL28335843 | 0.81 | DPP4 (0.54) | DPP4TTRAKR1C2AKR1C1AKR1C4 | |
| SCHEMBL9040690 | 0.80 | TTR (0.48) | DPP4TTRAKR1C2AKR1C1AKR1C4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119517408-A | Method for establishing death prediction model of new-onset type 2 diabetes and application | 中南大学湘雅二医院 | 2025-02-25 | — | — | CN | claimed |
| US-20220221433-A1 | MASS SPECTROMETRY ASSAY METHODS FOR DETECTION OF METABOLITES | METABOLON, INC. | 2022-07-14 | — | — | US | claimed |
| EP-3977112-A1 | MASS SPECTROMETRY ASSAY METHODS FOR DETECTION OF METABOLITES | Metabolon Inc. (US) | 2022-04-06 | — | — | EP | claimed |
| CN-113892029-A | Mass spectrometry method for detecting metabolites | 梅塔博隆股份有限公司 | 2022-01-04 | — | — | CN | claimed |
| CN-113816940-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-21 | — | — | CN | claimed |
| CN-113754634-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-07 | — | — | CN | claimed |
| WO-2020242744-A1 | MASS SPECTROMETRY ASSAY METHODS FOR DETECTION OF METABOLITES | METABOLON, INC. (US) | 2020-12-03 | — | — | WO | claimed |
| WO-2005021581-A2 | INDUCERS OF PLANT DISEASE RESISTANCE | VALENT BIOSCIENCES CORPORATION (US) | 2005-03-10 | — | — | WO | claimed |
| US-20050050587-A1 | Inducers of plant disease resistance | VALENT BIOSCIENCES CORPORATION | 2005-03-03 | — | — | US | claimed |
| US-20260107968-A1 | END PLUG COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107972-A1 | AEROSOL GENERATING GEL MATERIAL COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107973-A1 | AEROSOL-MODIFYING ADDITIVE COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107969-A1 | AEROSOL GENERATING MATERIAL COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107971-A1 | AEROSOL GENERATING MATERIAL IN DISCRETE PORTIONS COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| WO-2015183801-A1 | NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES | R. J. REYNOLDS TOBACCO COMPANY (US) | 2015-12-03 | — | — | WO | disclosed |
| US-20150344456-A1 | NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES | R.J. REYNOLDS TOBACCO COMPANY | 2015-12-03 | — | — | US | disclosed |
| WO-2005021581-A2 | INDUCERS OF PLANT DISEASE RESISTANCE | VALENT BIOSCIENCES CORPORATION (US) | 2005-03-10 | — | — | WO | disclosed |
| US-20050050587-A1 | Inducers of plant disease resistance | VALENT BIOSCIENCES CORPORATION | 2005-03-03 | — | — | US | disclosed |
| US-20030212074-A1 | Phosphate transport inhibitors | SMITHKLINE BEECHAM CORPORATION | 2003-11-13 | — | — | US | disclosed |
| WO-2001082924-A1 | PHOSPHATE TRANSPORT INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260107971-A1 | AEROSOL GENERATING MATERIAL IN DISCRETE PORTIONS COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHRM3, CHRM1 | DPP4 4317/4885TTR 1234/4885AKR1C2 3007/4885 |
| US-20260107968-A1 | END PLUG COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE | ALK, EXOSC4, EXOSC9 | DPP4 3033/4885TTR 1438/4885AKR1C2 3511/4885 |
| US-20260107969-A1 | AEROSOL GENERATING MATERIAL COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | CHRM1, CHRM3, ATRIP | DPP4 3733/4885TTR 1999/4885AKR1C2 2197/4885 |
| US-20260107973-A1 | AEROSOL-MODIFYING ADDITIVE COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | CHRM3, CHRM1, CHRM2 | DPP4 3767/4885TTR 1354/4885AKR1C2 3187/4885 |
| US-20030212074-A1 | Phosphate transport inhibitors | SLC34A2, SLC34A3, SLC34A1 | DPP4 382/4885TTR 1440/4885AKR1C2 2365/4885 |
| US-20260107972-A1 | AEROSOL GENERATING GEL MATERIAL COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | ACTN1, ARPC3, ARPC4 | DPP4 4240/4885TTR 1327/4885AKR1C2 2984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.